Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccines01:21

Vaccines

2
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
2
Vaccine Production01:23

Vaccine Production

9
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
9
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

3
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
3
Vaccinations01:51

Vaccinations

53.3K
Overview
53.3K
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

1.4K
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Theoretical and Centrifuge Modeling Experimental Monitoring Study on the Seismic Behavior of an Inclined Crack in a Slope.

Sensors (Basel, Switzerland)·2026
Same author

Target degradation of CASPASE-1 for alleviation of inflammation in sepsis <i>via</i> optogenetically engineered extracellular vesicles.

Acta pharmaceutica Sinica. B·2026
Same author

Targeting Soluble PD-1 Alleviates Peritoneal Fibrosis by Modulating PD-L1 Recycling and Mesothelial-Mesenchymal Transition.

Translational research : the journal of laboratory and clinical medicine·2026
Same author

Bioengineered JMJD3-PROTAC targeted epigenetic immunotherapy strategy for diabetic periodontitis.

Journal of advanced research·2026
Same author

Bio-recruiting hydrogel targeting mitochondrial homeostasis under neutrophil extracellular traps for diabetic wound repair.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026

Related Experiment Video

Updated: Mar 20, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K

Potential Strategies for Bacterial Infection Control: Outer Membrane Vesicle Based Bacterial Vaccines.

Qingzhe Li1,2,3, Lifei Guo1,2,4, Li Fan1

  • 1Department of Burns and Cutaneous Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Advanced Healthcare Materials
|March 19, 2026
PubMed
Summary

Outer membrane vesicles (OMVs) offer a promising strategy to combat rising bacterial resistance and superbacteria. These bacterial nanoparticles enhance vaccine immunogenicity and antigen delivery, providing new avenues for infectious disease treatment.

Keywords:
bacterial infectionimmune modulationouter membrane vesiclesvaccines

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.2K

Related Experiment Videos

Last Updated: Mar 20, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.2K

Area of Science:

  • Immunology
  • Microbiology
  • Biotechnology

Background:

  • Bacterial infections are a leading global cause of mortality.
  • Increasing bacterial resistance and the rise of superbacteria necessitate novel prevention and treatment strategies.
  • Bacterial vaccines are crucial for infection prevention.

Purpose of the Study:

  • To review existing bacterial vaccines, highlighting their classifications, advantages, and disadvantages.
  • To discuss the principles and challenges of developing vaccines based on bacterial outer membrane vesicles (OMVs).
  • To explore OMVs as an innovative platform for novel vaccine development against infectious diseases.

Main Methods:

  • Literature review of current bacterial vaccines.
  • Analysis of the composition and properties of bacterial outer membrane vesicles (OMVs).
  • Evaluation of OMV engineering for antigen display and immune response enhancement.

Main Results:

  • Bacterial outer membrane vesicles (OMVs) possess inherent adjuvant properties and antigen-carrying capabilities.
  • OMVs can enhance both humoral and cellular immune responses, addressing the low immunogenicity of some vaccines.
  • Engineered OMV surfaces can display diverse antigens, making them versatile vaccine platforms.

Conclusions:

  • OMVs represent an ideal platform for developing innovative vaccines against bacterial infections.
  • OMV-based vaccines show potential for overcoming limitations of traditional vaccines.
  • This review provides insights into OMV vaccine development for combating infectious diseases and antibiotic resistance.